GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Net Margin %

Microbix Biosystems (TSX:MBX) Net Margin % : 0.39% (As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Microbix Biosystems's Net Income for the three months ended in Mar. 2025 was C$0.02 Mil. Microbix Biosystems's Revenue for the three months ended in Mar. 2025 was C$5.33 Mil. Therefore, Microbix Biosystems's net margin for the quarter that ended in Mar. 2025 was 0.39%.

The historical rank and industry rank for Microbix Biosystems's Net Margin % or its related term are showing as below:

TSX:MBX' s Net Margin % Range Over the Past 10 Years
Min: -68.92   Med: 3.58   Max: 17.39
Current: 6.89


TSX:MBX's Net Margin % is ranked better than
78.33% of 983 companies
in the Biotechnology industry
Industry Median: -110.23 vs TSX:MBX: 6.89

Microbix Biosystems Net Margin % Historical Data

The historical data trend for Microbix Biosystems's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Net Margin % Chart

Microbix Biosystems Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -59.17 17.39 9.38 -0.24 13.86

Microbix Biosystems Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.71 4.88 6.99 14.18 0.39

Competitive Comparison of Microbix Biosystems's Net Margin %

For the Biotechnology subindustry, Microbix Biosystems's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Net Margin % distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Net Margin % falls into.


;
;

Microbix Biosystems Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Microbix Biosystems's Net Margin for the fiscal year that ended in Sep. 2024 is calculated as

Net Margin=Net Income (A: Sep. 2024 )/Revenue (A: Sep. 2024 )
=3.52/25.394
=13.86 %

Microbix Biosystems's Net Margin for the quarter that ended in Mar. 2025 is calculated as

Net Margin=Net Income (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=0.021/5.325
=0.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbix Biosystems  (TSX:MBX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Microbix Biosystems Net Margin % Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbix Biosystems Business Description

Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
Executives
James Stuart Currie Senior Officer
Mark Adrian Luscher Senior Officer
Bo Hollas Director
Jennifer Anne Stewart Director
Cameron Lionel Groome Director, Senior Officer
Kenneth Hughes Senior Officer
Martin Marino Director
Peter Martin Blecher Director
Philip Jonathan Casselli Senior Officer
Steven Trevor Hagerman Senior Officer
Damian Klimaszewski Senior Officer
Anthony J. Giovinazzo Director